Cite
HARVARD Citation
Frias, J. et al. (2023). Safety and efficacy of once-weekly basal insulin Fc in people with type 2 diabetes previously treated with basal insulin: a multicentre, open-label, randomised, phase 2 study. Lancet. 11 (3), pp. 158-168. [Online].